| 23/07/26 | 11:11:00 | 23 Jul 2026 | | Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing | GNW |
| 28/04/26 | 07:00:00 | 28 Apr 2026 | | Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study | GNW |
| 31/01/22 | 07:00:08 | 31 Jan 2022 | | Update on COVIDITY Phase 1 clinical trial | RNS |
| 26/01/22 | 07:00:06 | 26 Jan 2022 | | Interim Results for the 6 months ended 31 Oct 2021 | RNS |
| 22/12/21 | 09:45:06 | 22 Dec 2021 | | Notice of Interim Results | RNS |
| 13/12/21 | 16:41:48 | 13 Dec 2021 | | Second Price Monitoring Extn | RNS |
| 13/12/21 | 16:36:49 | 13 Dec 2021 | | Price Monitoring Extension | RNS |
| 23/11/21 | 15:58:17 | 23 Nov 2021 | | Result of AGM | RNS |
| 19/11/21 | 07:00:03 | 19 Nov 2021 | | First patient dosed in SCIB1 Phase 2 trial | RNS |
| 03/11/21 | 10:28:23 | 3 Nov 2021 | | Director Dealing | RNS |
| 02/11/21 | 10:07:03 | 2 Nov 2021 | | Director Dealing | RNS |
| 01/11/21 | 09:50:21 | 1 Nov 2021 | | Notice of Annual General Meeting | RNS |
| 29/10/21 | 07:00:06 | 29 Oct 2021 | | Results for the year ended 30 April 2021 | RNS |
| 28/10/21 | 11:23:15 | 28 Oct 2021 | | Extension of CLN Redemption Dates | RNS |
| 19/10/21 | 07:00:08 | 19 Oct 2021 | | New facilities at The Oxford Science Park | RNS |
| 15/10/21 | 07:00:04 | 15 Oct 2021 | | Notice of Final Results | RNS |
| 05/10/21 | 16:22:54 | 5 Oct 2021 | | First subject dosed in COVIDITY clinical trial | RNS |
| 09/09/21 | 16:31:54 | 9 Sept 2021 | | PDMR dealing | RNS |
| 26/08/21 | 07:00:02 | 26 Aug 2021 | | Modi-1 Phase I/II CTA approved by MHRA | RNS |
| 17/08/21 | 07:00:04 | 17 Aug 2021 | | Scancell selects PharmaJet’s Needle-free Systems | RNS |
| 30/07/21 | 09:52:19 | 30 Jul 2021 | | Director Dealing | RNS |
| 29/07/21 | 07:00:07 | 29 Jul 2021 | | COVIDITY Phase 1 trial application in SA approved | RNS |
| 28/07/21 | 17:00:02 | 28 Jul 2021 | | Lindy Durrant appointed CEO of Scancell | RNS |
| 22/06/21 | 07:00:03 | 22 Jun 2021 | | COVIDITY trial planned in South Africa and UK | RNS |
| 15/06/21 | 07:00:09 | 15 Jun 2021 | | Appointment of Joint Broker | RNS |
| 08/06/21 | 16:41:11 | 8 Jun 2021 | | Second Price Monitoring Extn | RNS |
| 08/06/21 | 16:35:43 | 8 Jun 2021 | | Price Monitoring Extension | RNS |
| 07/06/21 | 08:49:17 | 7 Jun 2021 | | Director Dealing | RNS |
| 30/04/21 | 10:48:33 | 30 Apr 2021 | | Director Dealing | RNS |
| 10/03/21 | 09:58:53 | 10 Mar 2021 | | Holding(s) in Company | RNS |
| 02/03/21 | 16:40:58 | 2 Mar 2021 | | Second Price Monitoring Extn | RNS |
| 02/03/21 | 16:35:37 | 2 Mar 2021 | | Price Monitoring Extension | RNS |
| 19/02/21 | 15:00:49 | 19 Feb 2021 | | Director Dealing | RNS |
| 19/02/21 | 07:00:06 | 19 Feb 2021 | | Director Dealing | RNS |
| 17/02/21 | 14:04:19 | 17 Feb 2021 | | Director Dealing | RNS |
| 16/02/21 | 15:00:06 | 16 Feb 2021 | | BLOCK LISTING SIX MONTHLY RETURN | RNS |
| 15/02/21 | 15:36:38 | 15 Feb 2021 | | Statement regarding share price movement | RNS |
| 15/02/21 | 11:05:36 | 15 Feb 2021 | | Second Price Monitoring Extn | RNS |
| 15/02/21 | 11:00:21 | 15 Feb 2021 | | Price Monitoring Extension | RNS |
| 15/02/21 | 09:05:48 | 15 Feb 2021 | | Second Price Monitoring Extn | RNS |
| 15/02/21 | 09:00:45 | 15 Feb 2021 | | Price Monitoring Extension | RNS |
| 03/02/21 | 07:00:03 | 3 Feb 2021 | | Update on SCIB2 clinical development partnership | RNS |
| 29/01/21 | 07:00:03 | 29 Jan 2021 | | Interim Results for the 6 months ended 31 Oct 2020 | RNS |
| 30/12/20 | 14:00:39 | 30 Dec 2020 | | Price Monitoring Extension | RNS |
| 30/12/20 | 11:05:48 | 30 Dec 2020 | | Second Price Monitoring Extn | RNS |
| 30/12/20 | 11:00:27 | 30 Dec 2020 | | Price Monitoring Extension | RNS |
| 18/12/20 | 16:41:17 | 18 Dec 2020 | | Second Price Monitoring Extn | RNS |
| 18/12/20 | 16:35:44 | 18 Dec 2020 | | Price Monitoring Extension | RNS |
| 18/12/20 | 14:05:32 | 18 Dec 2020 | | Second Price Monitoring Extn | RNS |
| 18/12/20 | 14:00:19 | 18 Dec 2020 | | Price Monitoring Extension | RNS |